CS
VASC

Credit Suisse’s Vascular Solutions Inc VASC Stock Holding History

Credit Suisse’s Portfolio VASC Stock Details VASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-22,460
Closed -$1.26M – 4276
2016
Q4 		$1.26M Buy
22,460
+1,751
+8% +$89.2K ﹤0.01% 2839
2016
Q3 		$999K Buy
20,709
+2,148
+12% +$100K ﹤0.01% 2956
2016
Q2 		$774K Buy
18,561
+7,194
+63% +$268K ﹤0.01% 3143
2016
Q1 		$369K Sell
11,367
-16,489
-59% -$475K ﹤0.01% 3412
2015
Q4 		$957K Buy
27,856
+15,067
+118% +$510K ﹤0.01% 2851
2015
Q3 		$414K Sell
12,789
-10,569
-45% -$379K ﹤0.01% 3528
2015
Q2 		$811K Buy
23,358
+14,768
+172% +$482K ﹤0.01% 3368
2015
Q1 		$260K Sell
8,590
-15,945
-65% -$458K ﹤0.01% 3947
2014
Q4 		$667K Buy
24,535
+4,006
+20% +$109K ﹤0.01% 3490
2014
Q3 		$508K Sell
20,529
-1,657
-7% -$39.3K ﹤0.01% 3637
2014
Q2 		$494K Buy
22,186
+9,591
+76% +$210K ﹤0.01% 3832
2014
Q1 		$329K Sell
12,595
-675
-5% -$16.8K ﹤0.01% 4027
2013
Q4 		$307K Buy
+13,270
New +$260K ﹤0.01% 4059
2013
Q3 		– Sell
-13,950
Closed -$205K – 4474
2013
Q2 		$205K Buy
+13,950
New +$219K ﹤0.01% 3844

Other funds holding VASC

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Credit Suisse's VASC Position: Q1 2017 in Review

Credit Suisse sold out of Vascular Solutions Inc (VASC) in Q1 2017, closing a stake of 22,460 shares — an estimated $1.26M sold.

Credit Suisse first reported a position in VASC in Q2 2013 and held it in 14 quarters. The position peaked at $1.26M in Q4 2016. 1 fund tracked by Wall St. Rank holds VASC as of Q1 2017.

  • Credit Suisse reported no remaining Vascular Solutions Inc position as of Q1 2017 after selling out during the quarter.
  • Credit Suisse sold 22,460 Vascular Solutions Inc shares in Q1 2017, an estimated $1.26M.
  • Credit Suisse first reported a position in Vascular Solutions Inc in Q2 2013 and held it in 14 quarters.
  • Credit Suisse's Vascular Solutions Inc position peaked at $1.26M in Q4 2016.
  • 1 fund tracked by Wall St. Rank held Vascular Solutions Inc as of Q1 2017.

Based on Credit Suisse's 13F filing for Q1 2017, filed 15 May 2017.